Literature DB >> 28669489

ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?

Alberto Martínez-Castelao1, José Luis Górriz2, Alberto Ortiz3, Juan F Navarro-González4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28669489     DOI: 10.1016/j.nefro.2017.06.001

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  4 in total

1.  Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Authors:  Beatriz Fernandez-Fernandez; Raul Fernandez-Prado; Jose Luis Górriz; Alberto Martinez-Castelao; Juan F Navarro-González; Esteban Porrini; María José Soler; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2019-05-31

2.  Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.

Authors:  Beatriz Aviles Bueno; Maria Jose Soler; Luis Perez-Belmonte; Anabel Jimenez Millan; Francisco Rivas Ruiz; Maria Dolores Garcia de Lucas
Journal:  Clin Kidney J       Date:  2022-04-11

Review 3.  GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists.

Authors:  José Luis Górriz; María José Soler; Juan F Navarro-González; Clara García-Carro; María Jesús Puchades; Luis D'Marco; Alberto Martínez Castelao; Beatriz Fernández-Fernández; Alberto Ortiz; Carmen Górriz-Zambrano; Jorge Navarro-Pérez; Juan José Gorgojo-Martinez
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

4.  Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.

Authors:  Amol Singhsakul; Ouppatham Supasyndh; Bancha Satirapoj
Journal:  J Diabetes Res       Date:  2019-11-13       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.